Top

Published in:

01-05-2016 | Erratum

Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?

Authors: D. T. Blumenthal, L. Mendel, F. Bokstein

Published in: Journal of Neuro-Oncology | Issue 3/2016

Excerpt

The author names were incorrectly captured in the initial online publication. The names have been corrected in the online publication (and show correctly in this erratum). …

Title: Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?
Authors: D. T. Blumenthal
L. Mendel
F. Bokstein
Publication date: 01-05-2016
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2016
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-016-2100-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2016

Positron emission tomography of high-grade gliomas

Is a modification of the radiotherapeutic target volume necessary after resection of glioblastomas with opening of the ventricles?

The modified lateral supraorbital approach for tumors of the petroclival junction extending into the anterior cerebellopontine area

Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancer

Long-term exposure to irinotecan reduces cell migration in glioma cells

Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopy